CommercialCoverageMedium impact
Extracorporeal Shock Wave Therapy (ESWT) for Muscoloskeletal Conditions and Soft Tissue Wounds 2.01.31
Excellus BlueCross BlueShield·Orthopedics, PM&R (Physical Medicine & Rehab), Pain Management +3 more·Bone & Joints (Orthopedic)
Effective date
Mar 19, 2026
We identified it
Jun 20, 2026
Summary
Excellus BlueCross BlueShield has updated their policy on Extracorporeal Shock Wave Therapy (ESWT) for musculoskeletal conditions and soft tissue wounds, effective March 19, 2026. The policy classifies ESWT as investigational for all musculoskeletal conditions including plantar fasciitis, tendinitis, fracture non-unions, and wound healing, meaning it will not be covered as medically necessary.
Action Required
Before March 19, 2026: Billing teams must update system to flag ESWT procedures as investigational/non-covered for Excellus BlueCross BlueShield plans. Providers should be notified that ESWT for musculoskeletal conditions and wound healing will be considered investigational and likely denied. Update prior authorization workflows to inform patients of potential coverage denials for these services.